GlassScriptPhysician profile
Daniel W Moyse
NPI 1508155524
$39,975.31
in general payments reported to CMS, 2019-2025
23 companies · $2,213 in 2025
The $2,213 reported for 2025 was more than what 84% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,343 · 2021: $5,831 · 2022: $1,918 · 2023: $7,128 · 2024: $6,093 · 2025: $2,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $3,275 · Education: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,153.32 |
| Travel and Lodging | $3,275.34 |
| Education | $1,005.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,924.19 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept Rf Probe, General - Pain Management |
| Medtronic, INC. | $7,772.15 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Nevro Corp. | $5,189.33 | 2019-2024 | Senza |
| Medtronic USA, INC. | $4,993.31 | 2019-2020 | |
| Abbott Laboratories | $3,384.03 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Saluda Medical Americas, INC. | $2,049.81 | 2023-2024 | Evoke, Evoke Scs |
| Mml US, INC. | $915.11 | 2021-2025 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $723.98 | 2024 | Iovera, Exparel |
| Spr Therapeutics, INC | $579.83 | 2022-2025 | Sprint Pns System |
| Vertos Medical, INC. | $532.06 | 2020-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $503.44 | 2024-2025 | Prospera |
| Globus Medical, INC. | $210.82 | 2025 | Vyrsa V1, Senza |
| Relievant Medsystems, INC. | $207.51 | 2023 | Intracept |
| Stryker Corporation | $168.00 | 2020-2025 | Mild Device Kit, Optablate |
| Si-Bone, INC. | $162.63 | 2023-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $148.12 | 2022 | |
| Nalu Medical, INC. | $145.44 | 2021 | |
| Edwards Lifesciences Corporation | $132.85 | 2019 | |
| Bioventus LLC | $81.67 | 2020 | |
| Tersera Therapeutics LLC | $57.31 | 2025 | Prialt |
| Zimmer Biomet Holdings, INC. | $39.10 | 2019 | |
| Alphatec Spine, INC | $28.72 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $25.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Moyse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.